Good morning, ladies and gentlemen, and welcome to the Oxford Immunotec Third Quarter 2014 Conference Call. As a reminder, this conference call is being recorded. It is now my pleasure to introduce your host, Mr. Mark Klausner, of Westwicke Partners.
Mark Klausner - Westwicke Partners
Good morning and thank you for joining us for Oxford Immunotec’s third quarter 2014 conference call. Joining us on today’s call are Oxford Immunotec’s Chief Executive Officer, Dr. Peter Wrighton-Smith; and its Chief Financial Officer, Rich Altieri.